BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 283 filers reported holding BLUEBIRD BIO INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $101,641 | -88.1% | 14,688 | +51.0% | 0.00% | -50.0% |
| Q4 2019 | $854,000 | +52.5% | 9,730 | +121.1% | 0.01% | 0.0% |
| Q2 2019 | $560,000 | -41.2% | 4,400 | -27.3% | 0.01% | -25.0% |
| Q1 2019 | $953,000 | +180.3% | 6,055 | +76.8% | 0.01% | +100.0% |
| Q4 2018 | $340,000 | -74.2% | 3,425 | -72.7% | 0.00% | -98.4% |
| Q2 2017 | $1,320,000 | +334.2% | 12,568 | +275.9% | 0.25% | +318.3% |
| Q1 2017 | $304,000 | – | 3,343 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
| Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
| PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
| Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
| Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
| Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
| Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
| Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
| Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
| Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |